Author archive for Neil Darkes
-
-
Re-balancing public perceptions of vaccination #wvclyon
/ By Neil Darkes / Antibodies, Flu, Partnering and Corporate strategy, Regulation and Policy, Uncategorized / 0 comments
-
ADITEC collaboration highlights new tech for R&D #wvclyon
/ By Neil Darkes / Uncategorized / 0 comments
-
#EuropeanCommission kicks off #wvclyon 2011
/ By Neil Darkes / Antibodies, Emerging Markets, Regulation and Policy, Uncategorized / 0 comments
-
TOP VALUE DRIVERS IN THE LIFE SCIENCE INDUSTRY
/ By Neil Darkes / Events, Partnering and Corporate strategy / 0 comments
-
Your 2012 funding prayers answered
/ By Neil Darkes / Emerging Markets, Events, Flu, Partnering and Corporate strategy, Therapeutic Vaccines / 0 comments
-
Speed Venturing at World Vaccine Congress Washington
/ By Neil Darkes / Events, Therapeutic Vaccines / 0 comments
-
2012 World Vaccine Congress Washington Survey Now Open
/ By Neil Darkes / Antibodies, Emerging Markets, Events, Flu, Partnering and Corporate strategy, Regulation and Policy, Therapeutic Vaccines / 0 comments
-
Poster Session Submissions NOW OPEN!!!
/ By Neil Darkes / Antibodies, Events, Regulation and Policy, Therapeutic Vaccines / 0 comments
-
2012 Vaccine Outsourcing Survey Results Posted – Download Here
/ By Neil Darkes / Events, Partnering and Corporate strategy / 0 comments
